Literature DB >> 35240102

Trends in PCSK9 inhibitor utilization in the United States, Europe, and other countries: An analysis of international sales data.

Joseph Edgar Blais1, Yue Wei1, Martin Knapp2, Ian C K Wong3, Li Wei4, Esther W Chan5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35240102     DOI： 10.1016/j.ahj.2022.02.008

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   5.099


× No keyword cloud information.
  1 in total

Review 1.  PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance.

Authors:  Xiaoming Jia; Mahmoud Al Rifai; Anum Saeed; Christie M Ballantyne; Salim S Virani
Journal:  Vasc Health Risk Manag       Date:  2022-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.